RHINOCORT TURBOHALER

국가: 아일랜드

언어: 영어

출처: HPRA (Health Products Regulatory Authority)

유효 성분:

BUDESONIDE

제공처:

AstraZeneca UK Limited

ATC 코드:

R01AD05

INN (국제 이름):

BUDESONIDE

복용량:

100 Mcg/Acutuation

약제 형태:

Nasal Powder

처방전 유형:

Product subject to prescription which may be renewed (B)

치료 영역:

budesonide

승인 상태:

Not Marketed

승인 날짜:

1995-09-19

환자 정보 전단

BODY TEXT SIZE
9.5 pt
SMALLEST TEXT SIZE
6.0 pt
567913-A02
30-06-17
PS10481
AZL010A
7851
SB
Rhinocort 100mcg Leaflet: Patient
IE
Black
Technical Info
Profile
Read all of this leaflet carefully before
you start using this medicine because it
contains important information for you.
•
Keep this leaflet. You may need to read
it again.
•
If you have any further questions, ask
your doctor or pharmacist.
•
This medicine has been prescribed for
you only. Do not pass it on to others. It
may harm them, even if their signs of
illness are the same as yours.
•
If you get any side effects, talk to your
doctor or pharmacist. This includes any
possible side effects not listed in this
leaflet. See section 4.
What is in this leaflet:
1.
What Rhinocort Turbohaler is and what
it is used for
2.
What you need to know before you use
Rhinocort Turbohaler
3.
How to use Rhinocort Turbohaler
4.
Possible side effects
5.
How to store Rhinocort Turbohaler
6.
Contents of the pack and other
information
1. What Rhinocort Turbohaler is and
what it is used for
The name of your medicine is
Rhinocort Turbohaler, 100 micrograms
per metered dose, Nasal Powder (called
Rhinocort Turbohaler in the rest of this
leaflet).
Rhinocort Turbohaler contains a medicine
called budesonide. This belongs to a group
of medicines called corticosteroids.
•
Corticosteroids help to reduce and
prevent inflammation.
•
Rhinocort Turbohaler is used to treat
the effects of allergies, such as hay
fever, and inflammation inside the nose
(rhinitis).
•
It can also stop these effects from
coming on.
•
It is also used to treat small growths
inside the nose (nasal polyps).
•
When you sniff through the Turbohaler,
the medicine is delivered to the inside of
your nose.
2. What you need to know before you
use Rhinocort Turbohaler
Do not use Rhinocort Turbohaler:
•
If you are allergic to budesonide.
If you are not sure if this applies to you, talk
to your doctor of pharmacist before using
Rhinocort Turbohaler.
Warnings and precautions
Talk to your doctor or pharmacist

제품 특성 요약

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Rhinocort Turbohaler, 100 micrograms per metered dose, Nasal Powder
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each metered dose contains 100 micrograms Budesonide.
For the full list of excipients see section 6.1.
3 PHARMACEUTICAL FORM
Nasal powder
Rhinocort Turbohaler is a metered dose, powder, nasal inhaler. White
to off-white rounded granules which break into a
fine nasal powder on inhalation.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Seasonal and perennial allergic rhinitis and vasomotor rhinitis.
Treatment of nasal polyps.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
POSOLOGY
TREATMENT OF SEASONAL AND PERENNIAL ALLERGIC RHINITIS AND VASOMOTOR
RHINITIS
ADULTS: The recommended dose is 400 mcg. Rhinocort Turbohaler may be
given once daily (two applications into each
nostril in the morning). When good effect has been achieved the dosage
may be reduced to one application into each
nostril.
Rhinocort Turbohaler may also be given twice daily (one application
into each nostril morning and evening).
If symptoms are not controlled, or persist for longer than 2 weeks of
treatment, medical advice should be sought.
Systemic effects of nasal corticosteroids may occur, particularly at
high doses prescribed for prolonged periods.
The patient should be informed that the full effect of Rhinocort
Turbohaler is not achieved until after a few days
treatment. Treatment of seasonal rhinitis should, if possible, start
before exposure to allergens.
ELDERLY: Dosage as for adults.
PAEDIATRIC POPULATION: There are insufficient data to recommend the
use of Rhinocort Turbohaler in children.
TREATMENT OF NASAL POLYPS
ADULTS: The recommended dose is 200 mcg twice daily (one application
into each nostril morning and evening).
If symptoms are not controlled, or persist for longer than 2 weeks of
treatment, medical advice should be sought.
Systemic effects of nasal corticosteroids may occur, particularly at
high doses prescribed for prolonged periods.
ELDERLY: Dosage as